Contact and place of performance
Eugene Jackson
Shreveport 71101
RFQ 36C25625Q1470 Question and Answer Reponses The purpose of this amendment is to: Clarify that this requirement is LPTA for brand name or equal to products. Clarify that all CLIN 0001-4026 are all brand name or equal to products and the OEM for the CLINs listed is Werfen. Address the questions submitted in response to the solicitation question deadline of 3pm 09/09/2025. See below Vendor 1: Question: Would it be po...
View moreThe Department of Veterans Affairs, Network Contract Office 16, has issued solicitation 36C25625Q1470 for the procurement of blood control reagents to be delivered in Shreveport. This combined synopsis and solicitation is classified under NAICS 325413 In-Vitro Diagnostic Substance Manufacturing and PSC 6550 IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS. The scope of the requirement covers products listed under CLINs 0001 through 4026, all of which are designated as brand name or equal to items produced by the original equipment manufacturer, Werfen.
The agency will evaluate offers based on the Lowest Price Technically Acceptable (LPTA) rationale. Recent updates to the solicitation address vendor inquiries, clarifying that the requirement for Anti-M reagent is a single CLIN despite an accidental duplication in previous documentation. This opportunity includes three attachments: two .docx files and one .pdf amendment. All responses must be submitted to Eugene Jackson by the deadline of September 12, 2025.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.